Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The continuing evolution of the drug discovery process in the pharmaceutical industry

1 Mar 2001

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biotechnology and Related Fields
Share to Computational Drug Discovery Methods

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 11347954
DOI: 10.1016/s0014-827x(01)01019-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The continuing evolution of the drug discovery process in the pharmaceutical industryPMID 11347954Read ↗

Drug discovery and development in the age of molecular medicine.Semantic proximity Read ↗

DRUG REPURPOSING-Overcoming the translational hurdles to clinical use.Semantic proximity Read ↗

Academic challenges on ATMPs’ development: a regulatory perspectiveSemantic proximity Read ↗

Pharmaceutical Drug Lifecycle: A Comprehensive Scientific Review of Research and Development Phases, Attrition Rates, and Global DisparitiesSemantic proximity Read ↗

“A Process-Based Approach to Conflicts of Interest”Semantic proximity Read ↗

Drug researchers take on 'superbugs'.Semantic proximity Read ↗

Potential strategies for increasing drug-discovery productivity.Semantic proximity Read ↗

Drug development: Mix and match.Semantic proximity Read ↗

A Decade of Innovation: Medicinal Products with New Active Substances Centrally Authorized Within EU Between 2011 and 2020Semantic proximity Read ↗

Ensuring Quality Medicine: A Comprehensive Overview of EMA and DGDA's History, Structure, and Functions.Semantic proximity Read ↗

Chemical proteomics and its application to drug discoverySemantic proximity Read ↗

Beyond QTPP: Introducing the Quality Target Administration (QTAP) Profile for Enteral Feeding Tube MedicationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.